Empowered Funds LLC Sells 11,078 Shares of Humana Inc. (NYSE:HUM)

Empowered Funds LLC decreased its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 74.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,836 shares of the insurance provider's stock after selling 11,078 shares during the period. Empowered Funds LLC's holdings in Humana were worth $973,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in HUM. Creative Financial Designs Inc. ADV boosted its position in shares of Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider's stock valued at $27,000 after purchasing an additional 61 shares in the last quarter. Ashton Thomas Securities LLC acquired a new stake in Humana in the third quarter valued at approximately $31,000. Your Advocates Ltd. LLP grew its stake in Humana by 81.8% in the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider's stock valued at $32,000 after acquiring an additional 45 shares during the period. Atwood & Palmer Inc. grew its stake in Humana by 64.5% in the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock valued at $39,000 after acquiring an additional 60 shares during the period. Finally, LRI Investments LLC grew its stake in Humana by 1,021.4% in the third quarter. LRI Investments LLC now owns 157 shares of the insurance provider's stock valued at $50,000 after acquiring an additional 143 shares during the period. Institutional investors own 92.38% of the company's stock.

Wall Street Analyst Weigh In

HUM has been the subject of a number of research reports. Wells Fargo & Company reduced their price objective on Humana from $387.00 to $290.00 and set an "overweight" rating for the company in a research note on Monday, November 4th. Cantor Fitzgerald reissued a "neutral" rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday, February 12th. Truist Financial lifted their target price on Humana from $260.00 to $290.00 and gave the company a "hold" rating in a research report on Monday, January 6th. TD Cowen lifted their target price on Humana from $261.00 to $268.00 and gave the company a "hold" rating in a research report on Monday, November 4th. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Nineteen equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $285.68.

Humana Stock Performance

Shares of NYSE:HUM traded down $15.53 during midday trading on Friday, reaching $255.77. 2,862,870 shares of the company traded hands, compared to its average volume of 1,707,253. The firm's fifty day moving average price is $269.41 and its two-hundred day moving average price is $290.45. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $30.80 billion, a price-to-earnings ratio of 25.71, a price-to-earnings-growth ratio of 2.00 and a beta of 0.56.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, equities analysts expect that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.38%. The ex-dividend date of this dividend is Friday, March 28th. Humana's dividend payout ratio is presently 35.58%.

Insider Activity at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.32% of the stock is currently owned by company insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.